Riskpilot← Back to searchSign inGet full accessIlluminatum Pirum AB
ABActiveOrg 5591521637Pontongränd 11Medical specialists activities · NACE 8622Est. 20181 employees
Revenue 2024
SEK 171K
-88% vs 2023
EBITDA margin
-38.0%
-110% vs 2023
Equity ratio
62.6%
Financial strength
Net profit 2024
SEK 77K
-82% vs 2023
| Revenue | SEK 171K | -88% |
| EBITDA | SEK -65K | -110% |
| Net profit | SEK 77K | -82% |
| Total assets | SEK 4M | -10% |
| Equity | SEK 2,5M | -8% |
| Employees | 1 | — |
Legal name
Illuminatum Pirum AB
Org number
5591521637
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
12 mars 2018
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska verka inom hälsa och sjukvård inklusive rådgivning, bedriva utbildning, undervisning och konsultuppdrag i anslutning därtill samt kapitalförvaltning och därmed förenlig verksamhet.
Address
Pontongränd 11
Email
rolf.e.gustafson@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 2 079 | 2 329 | 1 963 | 1 421 | 171 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 1 361 | 1 526 | 1 126 | 646 | −65 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 1 361 | 1 526 | 1 126 | 646 | −65 |
| Net financials | 146 | −313 | −2 | 85 | 4 |
| Profit before tax | 1 130 | 984 | 840 | 562 | 110 |
| Tax | −242 | −203 | −152 | −122 | −33 |
| Net profit | 888 | 781 | 688 | 440 | 77 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 2 874 | 3 628 | 4 312 | 4 379 | 3 951 |
| Equity | 1 638 | 2 162 | 2 560 | 2 697 | 2 472 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 378 | 295 | 297 | 59 | 28 |
| Total debt | 378 | 295 | 297 | 59 | 28 |
EBITDA margin
-38.0%
This company
15.8%
Market median
-341% vs market
20202024
Equity ratio
62.6%
This company
38.2%
Market median
+64% vs market
20202024
Return on equity
3.1%
This company
18.4%
Market median
-83% vs market
20202024
Net profit margin
45.0%
This company
8.1%
Market median
+456% vs market
20202024
Asset turnover
0.04×
This company
1.12×
Market median
-96% vs market
20202024
Debt / equity
0.60×
This company
0.62×
Market median
+3% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
RE Chief Executive Officer | Chief Executive Officer | 2020 |
| Former (2) | ||
AM Chief Auditor | Chief Auditor | 2022 – 2022 |
SK Chief Auditor | Chief Auditor | 2020 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2020 | |
| Former (1) | ||
| Board of Directors | 2020 – 2024 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Illuminatum Pirum AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Rolf Einar Gustafsson | Chief Executive Officer | 0 companies |
| Anna M E Lundeborn Bengtsson | Chief Auditor | 0 companies |
| Siv Katrine Elbra | Chief Auditor | 0 companies |
| Kennet Tommy Oxelgren | Deputy Board Member | 0 companies |
| Ann Elisabeth Maria Gardulf | Board of Directors | 0 companies |